Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aff47ee7-21cb-4375-908e-0b81bc4160af
Date 4/7/2014
Company Name Lycera
Mailing Address 2800 Plymouth Rd. Ann Arbor, MI 48109 USA
Company Description Lycera is an early-stage pharmaceutical company developing first-in-class drugs to treat immune disorders. Lycera’s technology platforms include proprietary small molecules that modulate a target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway.
Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.